Jane Street »

Regulus Therapeutics shares owned by Jane Street

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Jane Street

Quarter filed Position value Share count Share price at filing
2024-09-30 $46k 30k 1.57
2023-03-31 $15k 18k 0.85

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Spdr Gold Tr Gold Shs (GLD)
Advanced Micro Devices Call Option (AMD)
Pdd Holdings Sponsored Ads Put Option (PDD)
Broadcom Put Option (AVGO)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Jane Street

Top funds holding Regulus Therapeutics

Federated Investors
NEA Management Company
Octagon Capital Advisors
BlackRock
Vanguard Group
BlackRock
Deep Track Capital
T. Rowe Price Associates
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Woodline Partners
DAFNA Capital Management
Point72 Asset Management
RA Capital Management

View all funds holding Regulus Therapeutics